Effects of Novel Fiber on Glucose Homeostasis in Individuals at Risk for Diabetes
Novel Fiber Effects on Glucose Metabolism and Insulin Sensitivity for Individuals at High Risk for Diabetes: a Randomized, Placebo-controlled, Double-blind, Parallel Group Clinical Trial
Sponsor: Cargill
Terminated
Stopped due to a non-safety-related issue with the beverage (test vehicle).
Other Insulin Resistance trials with similar outcome
A NA clinical study on Insulin Resistance, this trial is terminated or withdrawn. The trial is conducted by Cargill and has accumulated 5 data snapshots since 2009. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Jan 2021 — Jul 2024 [monthly]
Terminated NA
-
Jun 2018 — Jan 2021 [monthly]
Terminated NA
-
Jan 2017 — Jun 2018 [monthly]
Terminated NA
First recorded
Jan 2009
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Cargill
For direct contact, visit the study record on ClinicalTrials.gov .